Webcast

Personal and Private: Can You Really Have It All?

Date: Wednesday, February 25, 2009

Time: 2 pm EST/11 am PST

Click here to register for free

Featured speakers: 
Nancy Phelan, Executive Director, Consumer Communications & eMarketing Wyeth
Stu Klein, General Manager, Lowe Alchemy
Joe Meadows, Vice President, Marketing and Creative Services, Catalina Health Resource

Order your copy!

2008/09 Pharmaceutical Marketers Directory

Save 10% off the cover rate ($295) with this special introductory offer.
Click here to order.

TOP JOBS

To find out about the MM&M Careers Section contact:
Scott Dattoli at 646-638-6015

New Drug Dossier

Click here to subscribe

MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. 

MM&M Service Directory Featured Company


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


Connect with Direct Marketing Specialists


Subscribe Today


MM&M offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

MM&M Career & Salary Survey Premium Edition

Are you making as much as your peers?

Complete the MM&M Career & Salary Survey 2008 now for a chance to win the latest Nintendo console. All responses will remain confidential. Click here to take the survey. 

 

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

ACCME vows crackdown, calls for "new paradigm" in CME

Days before a critical AMA House of Delegates vote on commercial support of CME, the Accreditation Council for Continuing Medical Education (ACCME) vowed to crack down on errant providers and proposed a "new paradigm" for commercial support.
 

First-year sales of GSK's Alli 'underwhelming,' analyst says

Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are "pretty underwhelming," one analyst tells the Associated Press.
 

Prevention survey: pols' bluster doesn't dent DTC

All the fury over DTC drug ads emanating from Washington hasn't dented their credibility with consumers, according to Rodale's 11th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs.
 

In Brief

Product news

The FDA has broadened the US indication for Novartis' Reclast (zoledronic acid) once-yearly injection to include the prevention of new clinical fractures in patients who have recently had a low-trauma hip fracture.
 

People news

Eli Lilly president of US operations Deirdre Connelly has been appointed to the President's Commission on White House Fellowships, which is composed of 20 to 30 citizens who represent a broad range of backgrounds and selects each class of White House Fellows.
 

Company news

Pfizer announced that it has entered into a $15 million dollar collaboration with the University of Pennsylvania School of Medicine.
 

Latest Features

PR Report: Trust & Credibility

Reversing pharma's ragged reputation is no easy task. But good intentions abound. Ben Comer reports on AstraZeneca's attempts to put transparency at the center of its efforts to build corporate trust and also gain ground in the cholesterol drug market
 

Second Coming?

Novo Nordisk associate director, Craig DeLarge, shares his insights on the various ways pharma can leverage and integrate the increasingly popular virtual world of Second Life into its marketing, education and training efforts.
 

Surviving the Shift

With pharmaceutical companies cutting advertising costs across all channels—consumer and professional alike—media planners and buyers are looking for ways to do more with less and are left wondering: How will online shake up the media mix?
 

Built for Speed

Generating pre-launch marketing awareness is turbo-charging pharma product market share gains. Harte-Hanks SVP, pharmaceutical markets, Julian Parreño discusses how 'hypermarketing' has helped Teva Neuroscience drive rapid market penetration
 

Headliner: Eisai Corporation's Robert Laverty

After nearly a quarter of a century in leadership communications roles at Bristol-Myers Squibb and Novartis, Robert Laverty signed on in April as VP, US corporate communications at Eisai Corporation of North America.
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.